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Schwann Cell Mitochondrial Metabolism Supports
Long-Term Axonal Survival and Peripheral Nerve Function
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Mitochondrial dysfunction is a common cause of peripheral neuropathies.While the role of neuron and axonal mitochondria in periph-
eral nerve disease is well appreciated, whether Schwann cell (SC)mitochondrial deficits contribute to peripheral neuropathies is unclear.
Here, we examine how SCmitochondrial dysfunction affects axonal survival and contributes to the decline of peripheral nerve function
bygeneratingmicewithSC-specificmitochondrial deficits. Thesemice (Tfam-SCKOs)wereproduced through the tissue-specific deletion
of the mitochondrial transcription factor A gene (Tfam), which is essential for mitochondrial DNA (mtDNA) transcription and mainte-
nance. Tfam-SCKOswere viable, but as they aged, theydevelopedaprogressive peripheral neuropathy characterizedbynerve conduction
abnormalities aswell as extensivemuscle denervation.Morphological examination of Tfam-SCKOnerves revealed early preferential loss
of small unmyelinated fibers followed by prominent demyelination and degeneration of larger-caliber axons. Tfam-SCKOs displayed
sensory andmotor deficits consistentwith this pathology. Remarkably, the severemtDNAdepletion and respiratory chain abnormalities
in Tfam-SCKO mice did not affect SC proliferation or survival. Mitochondrial function in SCs is therefore essential for maintenance of
axonal survival and normal peripheral nerve function, suggesting that SC mitochondrial dysfunction contributes to human peripheral
neuropathies.
Introduction
Peripheral neuropathies are a heterogeneous group of disorders
characterized by peripheral nerve abnormalities. With an inci-
dence of up to 8% in elderly populations, peripheral neuropa-
thies are a common cause of substantial morbidity and constitute
a significant economic and societal burden (Hughes, 2002). The
etiology for these diseases is varied, ranging from vascular and
metabolic irregularities to genetic mutations. Despite this appar-
ent diversity, mitochondrial derangements have emerged as a
common cause of many types of peripheral neuropathy. A num-
ber of mutations that affect mitochondrial function are now
thought to be responsible for several forms of inherited neurop-
athies (Niemann et al., 2006). Similarly, diabetic neuropathy, the
most prevalent formof peripheral nerve disease, is also associated
with abnormalities in mitochondrial morphology and metabo-
lism (Fernyhough et al., 2003). With the hope of developing new
therapies, therefore, much effort is being devoted to understand-
ing how mitochondrial deficiencies influence nerve function.
In recent years, significant progress has been made in eluci-
dating the role of axonal mitochondria in peripheral neuropa-
thies (Baloh, 2008). Peripheral nerve axons, however, do not
function in isolation. Schwann cells (SCs), themain glial cell type
in the PNS, are intimately associated with all peripheral nerve
axons and are essential for their long-term preservation and sur-
vival (Chen et al., 2003; Reddy et al., 2003;Meyer zuHorste et al.,
2007). Mitochondrial dysfunction in SCs is thus likely to partic-
ipate in the disease progression in peripheral neuropathies. In
fact, pathological mitochondria in neuropathic nerves are often
localized to SCs (Schroder, 1993; Kalichman et al., 1998). The
contribution of SC mitochondrial dysfunction to the pathology
observed in peripheral nerve diseases, however, is poorly under-
stood and remains largely unexplored.
With the goal of understanding whether SC mitochondrial
abnormalities affect axonal survival and contribute to the decline
of patients suffering fromperipheral nerve diseases, we generated
mice with impaired mitochondrial function exclusively in SCs.
These Tfam-SCKO mice were generated through the tissue-
specific deletion of themitochondrial transcription factor A gene
(Tfam), which is required for mitochondrial DNA (mtDNA)
transcription and replication (Larsson et al., 1998). Here, we
show that mitochondrial function in SCs is essential for mainte-
nance of axonal survival and normal peripheral nerve function.
Importantly, SCmitochondrial dysfunction alone recapitulated a
number of critical features of human neuropathies. Remarkably,
the severemtDNA depletion and respiratory chain abnormalities
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in Tfam-SCKOmice did not affect SC survival. SCmitochondrial
dysfunction, therefore, is a likely contributor to the impairment
of patients suffering from peripheral neuropathies.
Materials andMethods
Matings of transgenic animals.All animal experiments were performed in
compliance with institutional animal protocols. TfamloxP/loxP mice in a
pure C57BL/6 background (Larsson et al., 1998) were crossed to P0-Cre





their control (ctrl) littermates (P0-Cre
/, Tfam loxP/loxP). TfamloxP/loxP mice
were also crossed tohomozygosity toRosa26-YFPreportermice.TfamloxP/loxP/
Rosa26-YFP/were thencrossed toP0-Cremiceusingananalogousbreeding
scheme. TfamloxP/loxP genotyping was performed as previously described
(Larsson et al., 1998).
Immunohistochemistry and cell quantification. The following primary
and secondary antibodies were used: rabbit anti-GFP (1:1000; Invitro-
gen), chicken anti-GFP (1:1000; Aves), rabbit anti-III tubulin (1:1000;
Covance), rabbit anti-phosphohistone 3 (1:200; Millipore), rabbit anti-
Kv1.1 (1:100; Abcam), rabbit anti-Nav1.6 (1:100; Millipore), mouse
anti-Caspr (1:1000; gift from Dr. Elior Peles, Weizmann Institute of
Science, Rehovot, Israel), anti-rabbit Cy3 (1:500; Jackson ImmunoRe-
search Laboratories), streptavidin-conjugated Cy3 (1:500; Jackson Im-
munoResearch Laboratories), anti-rabbit Alexa 488 (1:500; Jackson
ImmunoResearch Laboratories), and anti-chicken Alexa 488 (1:500;
Jackson ImmunoResearch Laboratories).
For immunohistochemical analysis of sciatic nerves, nerves were dis-
sected, immersion fixed in 4% paraformaldehyde for 2 h, rinsed with
PBS, and cryoprotected in 30% sucrose. Sciatic nerves were then embed-
ded in Tissue-Tek OCT compound (Sakura Finetek) and sectioned at 6
m. For analysis of DRGs, mice were transcardially perfused with 4%
paraformaldehyde. The entire spinal cord was then dissected, postfixed
in PFA overnight, rinsed in PBS, and cryoprotected in 30% sucrose. After
cryoprotection, DRGs were dissected, embedded in Tissue-Tek OCT
compound, and sectioned at 6m. For analysis of footpads, footpad skin
was removed from the plantar surface of the hindpaw, immersion fixed
in Zamboni’s fixative for 2 h, rinsed with PBS, and cryoprotected in 30%
sucrose. Skin was sectioned at 30m in a plane perpendicular to the skin
surface. For analysis of teased nerve fibers, mouse sciatic nerves were
dissected and incubated in 4% paraformaldehyde in PBS for 30 min at
room temperature. The nerves were washed three times in PBS for 5min
and desheathed, and bundles of nerve were dissected with fine needles in
PBS on Fisherbrand Superfrost Plus microscope slides. Slides were air
dried for at least 2 h at room temperature and stored at 20°C until
staining.
All frozen sections were immunostained by postfixing in ice-cold ac-
etone at20°C for 10 min and blocking in 10% horse serum (DRG and
footpads) or 5% fish skin gelatin (sciatic nerve and teased fibers) in
PBS–0.2% Triton for 1 h at room temperature. Sections were then incu-
bated with primary antibody diluted in blocking buffer overnight at 4°C.
Secondary antibody incubation was performed at room temperature for
1 h also in blocking buffer. TUNEL staining was performed as previously
described (Grinspan et al., 1996). After all stainings, sections were
mounted with Vectashield Mounting Medium with DAPI (Vector Lab-
oratories) for microscopic visualization. Images were captured using an
upright microscope equipped for epifluorescence microscopy (Nikon
80i; CoolSnapES camera) andwere processed usingMetaMorph, ImageJ,
and Gimp software using global adjustments in brightness and contrast.
All cell number quantifications were performed by counting the cells
of interest in four randomly selected regions in longitudinal nerve sec-
tions from each animal assessed (at least three mice per genotype at each
age) at a 20magnification. Epidermal innervation density was quanti-
fied by tracing the dermal–epidermal border and determining the num-
ber of fibers that crossed this borders as previously described (Golden et
al., 2010).
Western blotting. Sciatic nerves were isolated, desheathed in PBS, and
immediately frozen in liquid nitrogen. Lysates were prepared by homog-
enizing the tissue by sonication in a buffer containing 150 mM sodium
chloride, 50mMHEPES, 1%NP-40, 1mM EDTA, 1mM sodium fluoride,
1 mM sodium orthovanadate, and Complete protease inhibitor mixture
(Roche Applied Science). The lysates were clarified by centrifugation at
14,000 rpm for 10min and quantified using theMicroBCAProtein Assay
kit (Pierce). For Western blotting, the proteins were separated by SDS-
PAGE and transferred to a PVDF membrane (Millipore). Membranes
were blocked in 5% milk in 0.5% TBS-Tween and incubated overnight
with the appropriate primary antibody. Following incubation with sec-
ondary antibodies conjugated toHRP (GEHealthcare),membraneswere
developed with SuperSignal West Dura substrate (Pierce). The primary
antibodies used were rabbit anti-Tfam (1:4000; Dr. Nils-Goran Larsson,
Max Planck Institute for Biology of Ageing, Cologne, Germany), mouse
anti-Porin 31HL (ab2) (1:200; Calbiochem), and mouse anti-tubulin (1:
1000; Sigma-Aldrich). The secondary antibodies used were anti-mouse and
anti-rabbit HRP (1:5000; Jackson ImmunoResearch Laboratories).
RNA and DNA preparation and quantitative real-time PCR. Sciatic
nerves were harvested from Tfam-SCKO mice at different ages and
immediately frozen in liquid nitrogen. For RNA isolation, tissue was
homogenized in Trizol reagent (Invitrogen) and total RNA prepared
according to the manufacturer’s protocol. For DNA isolation, tissue
was digested and DNA isolated using DNeasy Blood and Tissue kit
(QIAGEN) according to the manufacturer’s protocol. DNA and RNA
concentration were quantified using an ND-1000 spectrophotometer
(Nanodrop Technologies).
For RNA, qRT-PCR cDNA was reverse transcribed from total RNA
using MMLV reverse transcriptase (Invitrogen). qRT-PCR was per-
formed using a SYBR Green-based detection system on a 7700 Sequence
Detector instrument (Applied Biosystems) as described previously (Na-
garajan et al., 2001). Glyceraldehyde-3-phosphate dehydrogenase ex-
pression was used to normalize samples and obtain relative expression
values that were used to calculate fold changes. mtDNA content was also
quantified by qRT-PCRusing a SYBRGreen-based detection systemon a
7700 Sequence Detector instrument (Applied Biosystems) in a similar
way as described previously (Nagarajan et al., 2001). Instead of cDNA,
however, 15 ng of total DNA was used per reaction. Primers that recog-
nized a region unique to the mitochondrial genome were used to deter-
mine the mtDNA content relative to a serial dilutions standard curve.
mtDNA content values were normalized to nuclear DNA content as
determined by a set of primers directed to the genomic locus of Smrt1.
DNA and RNA qRT-PCR primer sequences were as follows (5–3):
Tfam: forward (F), CAGGAGGCAAAGGATGATTC; reverse (R),
ATGTCTCCGGATCGTTTCAC; GAPDH: F, TGCCCCCATGTTTGT-
GATG; R, TGTGGTCATGAGCCCTTCC; mt-ND2: F, CGCCCCATTC-
CACTTCTGATTACC; R, TTAAGTCCTCCTCATGCCCCTATG;
mt-Cox1: F, GAACCCTCTATCTACTATTCGG; R, CAAGTCAGTTTC-
CAAAGCCT; SDHB: F, TGTAGAGAAGGCATCTGTGG; R,
CGTAGAAGTTACTCAAATCAGGG; mtDNA: F, AAGTCGTAA-
CAAGGTAAGCA; R, ATATTTGTGTAGGGCTAGGG; Nuc.DNA: F,
GGGTATATTTTTGATACCTTCAATGAGTTA; R,
TCTGAAACAGTAGGTAGAGACCAAAGC.
Mitochondrial isolation, respiratory enzyme activity measurements, and
respirometry. For mitochondrial isolation, four sciatic nerves were dis-
sected, desheathed, mechanically dissociated, digested with collagenase
for 20 min, and pooled together in 2 ml of homogenization buffer (HM)
containing 0.22 M mannitol, 70 mM sucrose, 10 mM Tris-HCl, 0.5 mM
EDTA, 1 mM EGTA, and 0.5% delipidated BSA. Nerves were homoge-
nized for2 min (12 strokes) using a Teflon-glass homogenizer turning
at 200 rpm. The homogenate was then centrifuged at 800 g for 10min.
The clarified supernatant was centrifuged at 8000 g for 10min, and the
pellet was resuspended in 1ml of HMbuffer without BSA and spun once
more at 7500 g. The resulting pellet was resuspended in 250 l of HM
buffer without BSA. The protein concentration of the resuspended mi-
tochondrial fractions was determined using a MicroBCAProtein Assay
kit (Pierce). Five micrograms of protein from these mitochondrial preps
were used to measure complex II and complex IV activity spectrophoto-
metrically as previously described (Birch-Machin and Turnbull, 2001).
For high-resolution respirometry, two sciatic nerves were dissected,
briefly digested with collagenase for 10 min, and then desheathed and
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fluffed using a pair of fine forceps. At this point, nerve respiration was
measured in a 2 ml chamber using an OROBOROS Oxygraph 2k (Oro-
boros) as previously described (Mancuso et al., 2010).
Surgical procedure.Micewere anesthetized by intraperitoneal injection
of 2-2-2 tribromoethanol at a dose of 500 mg/kg. The sciatic nerve was
exposed at the hip and a reproducible crush injury was created by using
no. 5 jeweler’s forceps for 30 s. The site of injury wasmarkedwith a single
10-0 nylon epineural suture. Nerve lesions were produced on the right
side and the contralateral nervewas left intact and served as the uninjured
control. At the appropriate time, nerveswere harvested and processed for
histology.
Nerve light and electron microscopy and morphometry. Sciatic nerves
from ctrl and Tfam-SCKO mice at different ages were dissected and
placed in 3% glutaraldehyde overnight. After washing with phosphate
buffer, nerves were postfixed in 1% osmium tetroxide in phosphate buf-
fer overnight at 4°C. Specimens were then dehydrated in graded alcohols
and embedded in 100% epoxy (Araldite 502). One-micrometer-thick
plastic-embedded sectionswere prepared and stainedwith toluidine blue
for light microscopy. For electron microscopy, thin sections were pre-
pared, stained with uranyl acetate and lead citrate, and photographed
with a JEOL 1200 electron microscope. All nerves underwent qualitative
assessment of neural architecture followed by detailed histomorphomet-
ric analysis performed as previously described (Hunter et al., 2007).
Nerve electrophysiology and electromyography. Electrophysiology and
electromyography were performed on mice at 2, 4, and 8 months of age
using a Viking Quest electromyography machine (Nicolet) as previously
described (Baloh et al., 2009). Briefly, mice were anesthetized with Aver-
tin and placed on a heating pad. For nerve electrophysiology, subcutane-
ous platinum subdermal EEG electrodes (0.4 mm diameter, 12 mm
length) (Viasys) were used. Stimulating electrodes were placed just above
the left ankle and the left sciatic notch for nerve stimulation. Recording
electrodes were placed in the footpad. Evoked compound motor action
potentials were obtained using supramaximal stimulation, and distance
between the two sites of stimulating electrodes was used to calculate
conduction velocity. For electromyography (EMG) recordings, a 27-
gauge, Teflon-coated, monopolar needle electrode with a 70 500 m
recording surface (PRO-37SAF; Electrode Store) was used. A 29 gauge
reference needle electrode (GRD-SAF; Electrode Store) was inserted sub-
cutaneously in close approximation to the recording electrode. A subder-
mal ground electrode was placed on the back. The recording electrode
was inserted into the tibialis anterior or gastrocnemius/soleus muscles,
and spontaneous electrical activity was recorded for 90 s.
Muscle histology.Gastrocnemius muscles were dissected fresh and im-
mediately frozen in isopentane cooled in liquid nitrogen. Cryostat sec-
tions of gastrocnemius muscle were cut at 10monto slides and stained
with hematoxylin and eosin.
Nerve cytochrome oxidase staining. Sciatic nerves were dissected fresh,
placed in Tissue-Tek OCT compound, and immediately frozen in iso-
pentane cooled in liquid nitrogen. Tissue was then sectioned at 6 m.
Sections were placed in an incubating solution containing sucrose (100
mg/ml), DAB (3,3-diaminobenzidine tetrahydrochloride 2) (0.6 mg/
ml), sodium phosphate buffer (final concentration, 0.05 M), catalase 3
(2.6 g/ml), and cytochrome c (1.6 mg/ml) for 60 min at room temper-
ature. After incubation, sections were washed three times with deionized
water, dehydrated in a series of ascending alcohols and cleared with
xylene, and mounted using Permount.
Behavioral testing. Behavioral testing was performed using male and
female Tfam-SCKO mice and littermate controls at 2 and 4 months of
age. The experimenter was blind to the genotypes of themice during data
acquisition. Noxious heat sensitivity (Hargreaves test) was determined as
previously described (Golden et al., 2010). Briefly, the thermal threshold
was determined by measuring the withdrawal latency to a radiant heat
source applied to the plantar surface of the hindpaw in five separate trials
for each hindpaw with a 15 min interval between trials. The withdrawal
threshold was determined by averaging the withdrawal latency obtained
in each of the trials. Mechanical sensitivity was determined using the von
Frey test. Beginning with the smallest filament and continuing from
smallest to largest, calibrated von Frey filaments were pressed to the
plantar surface of the hindpaw until the filament just bent. The with-
drawal threshold is defined as the force that produces a withdrawal re-
sponse in three of five consecutive applications within one trial. The
threshold was determined in three trials per hindpaw with a 15 min
interval between trials. An accelerating rotarod was used to evaluate mo-
tor coordination and balance. Five consecutive acceleration trials were
performed with a 5 min interval between trials as described previously
(Montana et al., 2009). Muscle strength was measured using an inverted
screen test as previously described (Golden et al., 2010).
Osmicated teased sciatic nerve fibers. Sciatic nerves were dissected and
immersion fixed in 3% glutaraldehyde overnight. After washing with 0.1
M phosphate buffer, nerves were incubated in 1% osmium tetroxide plus
1.5% potassium ferricyanide in 0.5 M phosphate buffer for 1 h. Nerves
were washed in PBS followed by incubation in 33, 66, and 100% glycerol/
PBS for 6 h each. Nerves were then treated with 0.6% Sudan Black dis-
solved in 70% ethanol at 25°C for 30 min, rinsed with 70% ethanol and
with water, and then placed back in 100% glycerol. Nerves were teased in
100% glycerol and coverslipped for imaging.
Statistical analysis. All values are expressed as mean  SEM. If not
stated otherwise, p values were determined by unpaired, two-tailed Stu-
dent’s t test. In all applicable figures, an asterisk (*) indicates statistical
significance and p values are indicated in the legends. All statistical anal-
yses were performed using Microsoft Excel 2007.
Results
Schwann cell-specific disruption of the Tfam gene
To study how mitochondrial dysfunction affects SCs and their
ability to support long-term axonal survival, we generated mice
with disrupted mitochondria only in SCs (Tfam-SCKOs). For
this purpose, we used a previously developed mouse with loxP-
flanked Tfam alleles (Tfam loxP) (Larsson et al., 1998) (Fig. 1a).
TFAM is a nuclearly encoded mitochondrial protein that is es-
sential for mtDNA maintenance, copy number regulation, and
transcription (Larsson et al., 1998; Ekstrand et al., 2004). Previ-
ous reports have shown that the deletion of Tfam in TfamloxP
homozygous mice that express cre-recombinase in a tissue of
interest results in severe tissue-specific mtDNA depletion and
mitochondrial respiratory chain deficiency (Larsson et al., 1998;
Wang et al., 1999; Silva et al., 2000; Sorensen et al., 2001; Wre-
denberg et al., 2002). This makes the tissue-specific deletion of
Tfam an effective way to induce mitochondrial dysfunction in a
selected population of cells.
We mated Tfam loxP mice to mice that express cre-
recombinase under the control of the P0 promoter (P0-Cre) (Fel-
tri et al., 1999). P0-Cremice are well established to induce specific
recombination of floxed genes in peripheral myelinating and
nonmyelinating SCs starting at E13.5–E14.5, but not in any other
central or peripheral neuron or glia (Feltri et al., 1999, 2002). We
confirmed this selectivity by crossing P0-Cre mice with Cre-
inducible Rosa26-YFP reporter animals. Indeed, yellow fluorescent
protein (YFP) fluorescence was visible inmost sciatic nerve SCs but
not in axons or perineurial cells. Similarly, YFP could also be seen in
most dorsal root ganglia SCs (satellite cells) but not inDRGneurons
(Fig. 1b). In agreement with previous reports, therefore, P0-Cre in-
duced selective recombination inmost peripheral SCs.
The observed P0-Cre-mediated excision of Tfam in SCs was
highly efficient. Analysis of TfammRNA and protein levels from
Tfam-SCKO sciatic nerve extracts showed an 80% reduction
compared with littermate controls (Fig. 1c,d). Considering that
an estimated 15% of endoneurial cells are P0-Cre negative fibro-
blast and macrophages (King, 2005) and that nerve extracts also
contain some perineurial and endothelial cells, the actual excision
rate of Tfam in SCs was probably near complete. Given the high
selectivity and efficiency of the P0-promoter driven expression of
cre-recombinase, we conclude that themating ofTfam loxP to P0-Cre
mice resulted in animals that lacked Tfam specifically in SCs.
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SCmtDNA depletion and respiratory dysfunction
in Tfam-SCKOs
To determine the functional effect of deleting Tfam in SCs, we
next assessedmtDNA copy number and transcript level in Tfam-
SCKO sciatic nerves. Consistent with the essential role of Tfam in
the maintenance, replication, and transcription of mtDNA
(Larsson et al., 1998; Ekstrand et al., 2004), as well as with pre-
vious reports describing tissue-specific Tfam knock-out mice
(Larsson et al., 1998;Wang et al., 1999; Silva et al., 2000; Sorensen et
al., 2001;Wredenberg et al., 2002), totalmtDNA content was found
to be significantly reduced in Tfam-SCKO nerves compared with
control animals (Fig. 2a). Similarly, tran-
scripts of two different mitochondrially en-
coded proteins (mt-ND2 and mt-Cox1)
were also severely depleted in the sciatic
nerves of Tfam-SCKO animals (Fig. 2b). As
expected, no differences in the transcript
levels of nuclearly encoded mitochondrial
proteins were observed (Fig. 2b).
The mitochondrial genome encodes
13 subunits that are essential components
of complexes I, III, IV, and V of the elec-
tron transport chain. The depletion of
mtDNA and mitochondrially encoded
transcripts following Tfam excision has
been previously shown to induce severe
respiratory chain deficiency (Larsson et
al., 1998; Wang et al., 1999; Silva et al.,
2000; Sorensen et al., 2001;Wredenberg et
al., 2002). To examine the dysfunction of
SC mitochondria in Tfam-SCKO mice,
we first assessed respiratory chain enzyme
activities in the sciatic nerves of 2-month-
old animals. At this age, Tfam has already
been efficiently excised in sciatic nerve
SCs and mtDNA content and transcripts
have been severely depleted (Figs. 1c,d,
2a,b). Mitochondria isolated from Tfam-
SCKO sciatic nerves showed a 60% reduc-
tion in cytochrome oxidase (COX) activity
(complex IV), which contains critical
mtDNA-encoded subunits (Fig. 2c). As ex-
pected, the activity of succinate dehydroge-
nase (SDH) (complex II), which is fully
nuclearly encoded, showed no significant
change in mitochondria isolated from
Tfam-SCKO sciatic nerves (data not
shown).
To further confirm the disruption of
SC mitochondria in Tfam-SCKO mice,
we next used high-resolution respirome-
try to measure mitochondrial respiration
under different substrates in permeabil-
ized 2-month-old Tfam-SCKO sciatic
nerves. Respiration induced by substrates
delivering electrons to complex I (pyru-
vate plus malate) was significantly im-
paired in Tfam-SCKO sciatic nerves
compared with littermate controls. Simi-
larly, respiration induced by the conver-
gent transport of electrons entering at
complexes I and II (using pyruvate plus
malate plus succinate as substrates),
which best corresponds to the mitochondrial substrate supply in
vivo (Gnaiger, 2009), was also significantly reduced in Tfam-
SCKO sciatic nerves compared with littermate controls. These
reductions in mitochondrial respiration in Tfam-SCKO nerves
are likely explained by defects in complexes I, III, and IV as these
complexes containmtDNA-encoded subunits. Respiration induced
by electrons entering at the level of complex II remained unchanged
inTfam-SCKOnerves,which is explainedby the fact that complex II
contains only nuclearly encoded subunits (Fig. 2d).
It should be emphasized that, while the functional deficits
described above were measured from whole Tfam-SCKO sciatic
Figure 1. P0-Cre deletes Tfam from SCs specifically and efficiently in Tfam-SCKOmice. a, Diagram of the targeted Tfam locus in
Tfam loxPmice.When Tfam loxPmiceare crossedwithmice that express Cre recombinaseunder the control of theP0promoter, exons
6 and 7 of Tfam are excised to produce Tfammice. b, YFP fluorescence in SCs (arrowheads) of longitudinal sciatic nerve sections
(ScN), aswell as satellite SCs (arrowheads) inDRGsofRosa26-YFP/P0-Cremice. P0-Cre induces recombination specifically in SCs and
excision-dependent YFP fluorescence is localized to regions of SC cytoplasmbut not to axons (Tuj1 and stars; note non-overlapping
Tuj1 and YFP staining) or DRG neuron cell bodies (stars). Scale bars: Top and bottom panels, 100m;middle magnified panel, 50
m. c, qRT-PCR results showing efficient depletion of Tfam mRNA in Tfam-SCKO sciatic nerves. Tfam mRNA levels in the sciatic
nerve of 1-month-old Tfam-SCKOswere decreased by 60% (p 0.001, two-tailed Student’s t test) comparedwith ctrl littermates.
By2monthsof ageTfammRNA levelswere reducedby85%(p0.002, two-tailedStudent’s t test) comparedwith ctrl littermates.
Reported values are normalized to GAPDH. Error bars indicate SEM. n 2 pools of 3 mice run in 3 independent experiments. d,
Western blot showing efficient depletion of Tfamprotein in the sciatic nerves of Tfam-SCKOmice comparedwith ctrl littermates by
2 months of age.
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nerves, they are a reflection of themtDNA
depletion and mitochondrial dysfunction
taking place specifically in SCs. The high
specificity of the P0-cre-mediated excision
of Tfam ensures this (Fig. 1b). Moreover,
COX enzymatic staining, which reflects
respiratory chain activity in individual
cells, showed reduced staining intensity in
the cell bodies of SCs in Tfam-SCKO sci-
atic nerves (Fig. 2e). Finally, electron mi-
croscopy of Tfam-SCKO nerves revealed
abundant abnormal, enlarged mitochon-
dria, sometimes with distorted cristae,
specifically in SC but not in axons (Fig.
2f). Together, our results confirm that, by
deleting Tfam specifically in SCs, we were
able to generate a mouse with disrupted
mitochondrial metabolism only in pe-
ripheral glia.
Tfam-SCKOs develop a progressive
degenerative peripheral neuropathy
Despite severe mtDNA and transcript
depletion as well as respiratory chain
dysfunction in their SCs, Tfam-SCKO an-
imals were born at the expected Mende-
lian ratios and survived to at least 12
months of age (the longest a Tfam-SCKO
was allowed to survive before it was
killed). Tfam-SCKO animals developed
normally andwere indistinguishable from
their control littermates up to 3 months
of age. Starting at 3–4 months of age,
however, Tfam-SCKOs showed signs of
muscle weakness and gait abnormality.
Tfam-SCKOs exhibited abnormal limb
clasping, mild tremors, and impaired co-
ordination, and developed a characteristic
“swimming gait.” These deficits progres-
sively worsened so that, by 8 months of
age, most Tfam-SCKOswere often unable
to support themselves on their hind legs
(Fig. 3a). Such motor abnormalities are
indicative of peripheral nerve disease and
have been previously described in other
mouse models of peripheral neuropathy
(Le et al., 2005; Ryu et al., 2007; Baloh et
al., 2009).
Reduced peripheral nerve conduction
velocity is a hallmark and diagnostic
marker of diabetic as well as other
mitochondria-related neuropathies (Ar-
ezzo and Zotova, 2002). To further char-
acterize the peripheral nerve deficits in
Tfam-SCKOs, we performed nerve con-
duction studies both on presymptomatic
and symptomatic mice. Nerve conduc-
tion velocity was significantly reduced in
Tfam-SCKO animals as early as 2 months of age and this deficit
persisted over time (Fig. 3c). Moreover, Tfam-SCKO mice dis-
playedmarked temporal dispersion at 4months of age (Fig. 3b,d).
Both these findings are suggestive of a progressive demyelinating
phenotype in Tfam-SCKO mice.
Interestingly, EMG of Tfam-SCKOs showed occasional fibril-
lation potentials and fasciculations at 2–3 months of age, which
became prominent at 4 months and continued to worsen with
increasing age (Fig. 3e) (data not shown). These EMG findings
reflect loss of muscle fiber innervation and spontaneous firing of
Figure 2. SC-specific excisionof Tfam inducesmtDNAand transcript depletionand respiratorydysfunction in Tfam-SCKOs.a, qRT-PCR
results showing depletion ofmtDNA content in the sciatic nerves of Tfam-SCKOmice comparedwith littermate ctrls.mtDNA contentwas
significantly reduced by 50% (p 0.01, two-tailed Student’s t test) in 2-month-old Tfam-SCKO sciatic nerves comparedwith ctrl nerves.
Reported values are normalized to nuclear DNA content. Error bars indicate SEM. n 3mice per genotype run in 2 independent experi-
ments. b, qRT-PCR results showing depletion of mitochondrially encoded electron transport chain subunit transcripts (mt-ND2 and
mt-Cox1) in Tfam-SCKO sciatic nerves. mRNA levels of these subunits were decreased 85% (p 0.02, two-tailed Student’s t test) in
2-month-oldTfam-SCKOsciaticnervescomparedwithctrl littermates. Incontrast, transcriptsofnuclearlyencodedelectrontransportchain
subunits (nuclear SDHB) are not depleted in Tfam-SCKO sciatic nerves. Reported values are normalized toGAPDH. Error bars indicate SEM.
n2pools of 3mice run in 3 independent experiments. c, Respiratory chain enzymeactivitymeasured frommitochondria isolated from
thesciaticnervesof2-month-oldTfam-SCKOnervesandctrl littermates.COXactivity (complex IV),whichcontainscriticalmtDNA-encoded
subunits, is reduced 65% (p 0.01, two-tailed Student’s t test) in Tfam-SCKOmice. Error bars indicate SEM. n 3 pools of 2 mice per
genotype.d, Mitochondrial respiration in 2-month-old Tfam-SCKO and littermate ctrl permeabilized sciatic nervesmeasured using high-
resolutionrespirometry.RespirationinducedbysubstratesdeliveringelectronstocomplexI (pyruvateplusmalate) is reducedby35%(p
0.04, two-tailed Student’s t test) in Tfam-SCKO sciatic nerves compared with littermate controls. Respiration induced by the convergent
transport of electrons entering at complexes I and II (using pyruvate plusmalate plus succinate as substrates) is decreased by 25% (p
0.04, two-tailed Student’s t test) in Tfam-SCKO sciatic nerves comparedwith littermate ctrls. Respiration induced by substrates delivering
electrons to complex II alone (succinate), which is fully nuclearly encoded, was not significantly changed in Tfam-SCKO nerves compared
withlittermatectrls.Errorbars indicateSEM.n5micepergenotype.e,COXenzymaticstainingof4-month-oldctrlandTfam-SCKOsciatic
nerves. The intense COX staining that localizes to SCs in ctrl nerves (arrowheads) is largely lost in Tfam-SCKOnerves, indicatingmitochon-
drial dysfunction specifically in this cell type. f, Electron micrographs of Tfam-SCKO sciatic nerves show abundant abnormal enlarged
mitochondria (arrowheads), oftenwithdistorted cristae.Aberrantmitochondriaaremainly found inSCs,while axonalmitochondria show
nomorphologicalabnormalities (arrows).Pathologicalmitochondriaarevisibleasearlyas1monthinTfam-SCKOnerves(top3panels)and
becomemore abundant as thesemice age (bottompanels from4-month-oldmice). Scale bars, 500 nm.
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motor units, and are often seen in human nerve diseases involv-
ing motor axon loss. Thus, our EMG results indicated a progres-
sive axonal degeneration phenotype in Tfam-SCKO mice. This
was confirmed by muscle histology, which revealed abundant
denervated atrophic muscle fibers (Fig. 3f). SC-specific mito-
chondrial dysfunction caused, therefore, a progressive peripheral
neuropathy characterized by both demyelination as well as ax-
onal degeneration.
Tfam-SCKOs display early preferential loss of small
unmyelinated fibers
To examine in detail the peripheral nerve abnormalities in Tfam-
SCKOs,we performedhistological and electronmicroscopy anal-
ysis of Tfam-SCKO sciatic nerves at different ages. Tfam-SCKO
nerves initially developed normally, and for the first 2–3 weeks of
life there were no obvious differences between ctrl and Tfam-
deficient nerves (see Notes). As early as 1 month of age, however,
Tfam-SCKO nerves started to display signs of pathology. Inter-
estingly, we found that these early abnormalities preferentially
affected, andwere initially limited to, small-caliber unmyelinated
fibers (C-fibers) (Fig. 4a–e).
Small-caliber fibers are normally associated with nonmyeli-
nating SCs, such that a single SC wraps aroundmultiple axons to
form a Remak bundle. The Remak bundle is delimited by a base-
mentmembrane and individual axons are kept separate fromone
another inside it by a thin extension of SC cytoplasm (Fig. 4e1). At
1 month, the structure of Remak bundles in Tfam-SCKO nerves
was clearly disrupted (Fig. 4d,e). Unmyelinated axons within a
Remak bundle were often found touching one another and inter-
spersed by pathological SC processes known as bands of Bungner
(Fig. 4e2). Moreover, degeneration of unmyelinated axons was
extensive and evidenced by free-floating, excess basement mem-
brane surrounding empty spaces previously occupied by axon
bundles (Fig. 4e2,e3). Precise quantification of small fiber loss in
the nerves of Tfam-SCKO mice, however, was not possible be-
cause of the difficulty of distinguishing abnormal unmyelinated
axons from SCprocesses forming bands of Bungner. Note that, at
this age (1 month old), large-caliber myelinated fibers (A fibers)
in Tfam-SCKO nerves appeared normal (Fig. 4a–c).
The unmyelinated fibers in Tfam-SCKO nerves quickly dete-
riorated, and by 2 months of age, most nonmyelinating SCs were
associated with unstructured, degenerating Remak bundles.
These bundles contained few intact axons and were often filled
with phagocytic vesicles and membranous debris, indicative of
axonal degeneration (Fig. 4e4). We confirmed the early degener-
ation of unmyelinated fibers observed in Tfam-SCKO sciatic
nerves by quantifying C-fiber density in the epidermis. Somatic
C-fibers are primarily high-threshold nociceptors that terminate
in the epidermis (Kennedy and Wendelschafer-Crabb, 1993). In
neuropathies characterized by loss of small unmyelinated fibers,
skin denervation is one of the initial signs of pathology and cor-
relates with disease severity (Ebenezer et al., 2007). While we did
not observe differences in epidermal fiber density at 1 month of
age, we found a significant decrease in skin innervation in
2-month-old Tfam-SCKOmice (Fig. 4f,g). This was again in con-
trast to large myelinated fibers, which at this age were just begin-
ning to show initial signs of pathology (Fig. 5a). Overall numbers
of dorsal root ganglion neurons in L3, whose axons project to the
sciatic nerve, were comparable in 2-month-old Tfam-SCKO and
ctrl mice (average total number of neurons: ctrl, 7048  186;
Tfam-SCKO, 7381 211.3; n 3 mice per genotype). Similarly,
TUNEL and cleaved caspase 3 immunostaining of the dorsal root
ganglion neurons whose axons project to the sciatic nerve (levels
L3–L5) showed no signs of cell death in either 2- or 4-month-old
Tfam-SCKOs (data not shown). The degeneration of small un-
myelinated fibers in the nerves of Tfam-SCKO mice was, there-
fore, a primary pathological event and was not secondary to
neuronal death.
Together, our results show that Tfam-SCKO mice initially
suffered early preferential loss of small unmyelinated fibers, sug-
gesting that these fibers are most sensitive to SC mitochondrial
dysfunction. The temporal progression of fiber loss in Tfam-
SCKO nerves is particularly interesting because early preferential
loss of small unmyelinated fibers has been reported in polyneu-
ropathies associated with diabetes and HIV/AIDS (Kennedy et
al., 1996;McArthur et al., 2005), diseases in whichmitochondrial
Figure3. Tfam-SCKOsdevelopaprogressivedegenerativeperipheralneuropathy.a,Photograph
of end-stage Tfam-SCKOmouse (	8months of age). At this stage, Tfam-SCKOs display a character-
istic swimminggait andareunable to support themselveson theirhind legs.b, Typicalnerve conduc-
tiontracefroma4-month-oldTfam-SCKOmouseshowingmarkedtemporaldispersion.Calibration:1
ms,1mV. c,d, Electrophysiological studiesofTfam-SCKOmiceshowthat, asearlyas2monthsofage,
thesemicehave significantly reducednerve conduction velocity (c) (p0.001, two-tailed Student’s
t test) compared with littermate ctrls. This deficit persists in 4-month-old animals (c) (p 0.001,
two-tailed Student’s t test), which also have severe temporal dispersion as shown by an increased
response duration (d) (p 0.001, two-tailed Student’s t test). These findings indicate segmental
demyelination.Errorbars indicateSEM.N4micepergenotypeateachage.e,Typicalelectromyog-
raphy traces froma4-month-old Tfam-SCKOmouse showing fibrillation (arrowheads) and fascicula-
tions (arrows), common findings in diseases involving motor axon loss, indicative of muscle fiber
denervation and motor unit degeneration/regeneration. These findings were never present in ctrl
littermates. Calibration: 50ms, 500V. f, Hematoxylin and eosin stain of the gastrocnemiusmuscle
from a ctrl and a Tfam-SCKO mouse showing scattered and grouped muscle fiber atrophy (arrow-
heads). This is characteristic ofmotor axondegeneration. Scale bar, 50m.
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dysfunction is known to occur (Dalakas et al., 2001; Fernyhough
et al., 2003).
Loss of large-caliber myelinated fibers in older Tfam-SCKOs
While Tfam-SCKOs suffered an early preferential loss of small
unmyelinated fibers, these mice also developed deficits in large-
caliber myelinated axons as they aged. Toluidine blue-stained
plastic sections of 2-month-old Tfam-SCKO sciatic nerves
showed early signs of axonal degeneration (Fig. 5a). This obser-
vation was confirmed by electron microscopic examination,
which revealed a few axons undergoing active demyelination and
Wallerian degeneration (data not shown). Note, however, that at
this age there was not a significant decrease in the number of
myelinating profiles in Tfam-SCKO nerves (Fig. 5b).
Severe axonal loss became prominent in Tfam-SCKOs by 4
months (Fig. 5a–c). At this age, the number of myelinating pro-
files in Tfam-SCKO nerves was greatly reduced compared with
control littermates (Fig. 5b). Degeneration of myelinated axons
continued to progress as Tfam-SCKO mice aged, and by 8
months of age the number of myelinating profiles in these ani-
mals was40% that of control littermates (Fig. 5a–c3). Electron
micrographs confirmed the severity of the axonal degeneration in
Tfam-SCKO nerves, revealing large portions of endoneurium
completely devoid of axons (Fig. 5c). Similarly, numerous axons
undergoing degenerationwere also visible.Detailedmorphomet-
ric analysis (Hunter et al., 2007) showed no differences in the size
distribution of myelinated axons in Tfam-SCKO nerves com-
pared with control littermates at different ages, indicating that
myelinated fibers of all calibers were susceptible to degeneration
(Fig. 5d). As in the case of small unmyelinated fibers, the degen-
eration of myelinated fibers was not secondary to neuronal death
since no TUNEL- or cleaved caspase 3-positive motor neurons
were observed in the spinal cords of either 2- or 4-month-old
Tfam-SCKOs (data not shown).
At 4 months, demyelination was also widespread in Tfam-
SCKOnerves. At this age, large-caliber axons without anymyelin
were a prominent pathological feature (Fig. 5c). Examination of
osmicated teased fibers from 4-month-old Tfam-SCKO nerves
confirmed the presence of segmental demyelination (Fig. 5e).
Consistent with demyelination, SCs actively digesting myelin de-
bris were present in Tfam-SCKO nerves at this age (Fig. 5c4).
Occasionally, axons surrounded by abnormally thin myelin were
also observed. Thin myelin was, however, not characteristic, and
in fact there was no difference in the overall g-ratio between
Tfam-SCKO and control nerves at different ages (data not
shown). Overall, these results show that extensive axonal degen-
eration and demyelination ensue when SCmitochondria are dis-
rupted. Normal SC mitochondrial function is therefore essential
for maintaining the interaction between myelinating SCs and
axons.
Figure 4. Tfam-SCKOs display early preferential loss of small unmyelinated fibers: a– c,
Toluidine blue-stained plastic sections of 1-month-old Tfam-SCKO sciatic nerve and littermate
ctrls (a) show that at this age there are no differences in the number ofmyelinated fibers (b) or
the extent of myelination ( g-ratio, axon area/fiber area) (c). Scale bar, 25 m. Error bars
indicate SEM. n  4 mice per genotype. d, Electron micrographs of 1-month-old ctrl and
Tfam-SCKO sciatic nerves show that, while large myelinated fibers are mostly normal in Tfam-
SCKO mice at this age (arrows), the structure of Remak bundles (arrowheads) is largely abnor-
mal. Scale bar, 2 m. e1–e4, Compared with ctrl littermates (e1), unmyelinated axons in
Tfam-SCKO Remak bundles are found touching one another (e2, e4, stars) and interspersed by
4
pathological SC processes known as bands of Bungner (e2, arrowheads). Free-floating excess
basement membrane (e2, e3, arrows) enclosing SC cytoplasm (e3, star) with few or no axons
left, indicative of extensive degeneration of unmyelinated axons, is also visible. By 2months of
age,most nonmyelinating SCs are associatedwith unstructured, degenerating Remak bundles,
containing abnormal axons (e4, star) and filled with phagocytic vesicles and membranous
debris (e4, arrowhead). Scale bar, 500 nm. f, Representative photographs of epidermal fiber
innervation (arrowheads) in the footpads of 2-month-old Tfam-SCKO and littermate ctrl mice.
Scale bar, 10m. g, Quantification of fiber density in the epidermis shows a 30% decrease in
Tfam-SCKO by 2months of age (p 0.02, two-tailed Student’s t test), indicating early degen-
eration of small unmyelinated C-fibers. Results reported are normalized to per unit area. Error
bars indicate SEM. n 3 mice per genotype at each age.
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Tfam-SCKOs have behavioral deficits consistent with early
loss of unmyelinated fibers followed by extensive
degeneration of myelinated axons
To determine the physiological effects and confirm the temporal
progression of the pathology observed in Tfam-SCKOnerves, we
performed a battery of sensorimotor tests in 2- and 4-month-old
animals. Behavioral tests that primarily assess the function of
small unmyelinated C-fibers were expected to show deficits in
both 2- and 4-month-old Tfam-SCKO mice. However, behav-
ioral paradigms looking mainly at the function of large myelin-
Figure 5. Degeneration of large-caliber myelinated fibers in older Tfam-SCKOs. a, b, Toluidine blue-stained plastic sections of Tfam-SCKO sciatic nerves and littermate ctrls at different ages (a)
and quantification of total number ofmyelinated profiles per nerve (b). At 2months, some initial signs of axonal degeneration are apparent (arrowhead) in Tfam-SCKO nerves, but at this age there
arenodifferences in thenumber ofmyelinated fibers (b). By 4months, there is prominent axonal degeneration, as shownbya significant decrease (p
0.001, two-tailed Student’s t test) in the total
number ofmyelinated profiles in Tfam-SCKOnerves. Axonal degenerationworsens by 8months of age (p
0.001, two-tailed Student’s t test). Scale bar, 25m. Error bars indicate SEM.n4mice
per genotype at each age. c1– c4, Electron micrographs of Tfam-SCKO nerves at different ages confirm that large myelinated fiber degeneration becomes prominent by 4 months of age (c2) and
worsens by 8 months (c3), as shown by large portions of endoneurium completely devoid of axons (stars). By 4 months of age, actively demyelinating and degenerating axons filled with
membranous debris (arrowheads) are also common in Tfam-SCKO nerves (c4). By this age, segmental demyelination as shown by large-caliber axons without myelin is also prominent (c2– c4,
arrows). This type of pathology is not visible in ctrl nerves (c1). Scale bar, 2m.d, Fiber size distribution analysis in Tfam-SCKO and ctrl littermate nerves at different ages. No differences in fiber size
distribution are evident despite severe axonal degeneration, indicating that myelinated fibers of all calibers are susceptible to degeneration. Error bars indicate SEM. n 4mice per group at each
age. e, Osmicated teased fibers from 4-month-old Tfam-SCKO nerves confirm the presence of segmental demyelination. Scale bar, 25m.
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ated fibers were predicted to show differences only in 4-month-
old Tfam-SCKO mice.
Small unmyelinated C-fibers have a primary role in nocicep-
tion. To examine the physiological effect of the early C-fiber loss
observed in Tfam-SCKOs, we assessed their sensitivity to a nox-
ious heat stimulus. When a noxious radiant heat stimulus was
applied to the hindpaw (Hargreaves test), Tfam-SCKOs dis-
played a longer withdrawal latency than their control littermates.
As expected, this reduced sensitivity to noxious heat stimuli was
detectable in 2-month-old animals and persisted as these mice
aged (Fig. 6a).
We also tested innocuous mechanical sensitivity in 2-month-
old Tfam-SCKOs using the von Frey test. Innocuous mechanical
sensitivity is another form of somatosensation, but, unlike noci-
ception, it is primarily mediated by myelinated fibers. Interest-
ingly, 2-month-old Tfam-SCKO animals showed no deficits in
the von Frey test compared with wild-type littermate controls
(average withdrawal threshold: ctrl, 0.86 0.08 g; Tfam-SCKO,
1.0  0.05 g; n  4 mice per genotype). The results from these
somatosensory studies supported the pathological observations
indicating early preferential loss of small unmyelinated fibers in
Tfam-SCKO mice.
Given that the axons of motor neurons are large myelinated
fibers, we next determined whether the pathology observed in
Tfam-SCKO nerves caused any abnormalities inmotor function.
As predicted, no motor deficits were detected in 2-month-old
Tfam-SCKOs (Fig. 6b,c). Four-month-old Tfam-SCKO animals,
however, spent significantly less time on an accelerating rotarod
(Fig. 6d) as well as on an inverted screen (Fig. 6b), indicating
abnormal coordination and muscle weakness. The results from
these motor studies are consistent with the observation that
large-caliber axons are not affected in Tfam-SCKO mice until
later in the disease. Together, our results confirm that Tfam-
SCKO mice initially suffered early preferential loss of small
unmyelinated fibers followed by extensive loss of large-caliber
myelinated axons.
SCmitochondrial dysfunction does not compromise SC
survival
To determine whether the axonal loss and demyelination ob-
served in Tfam-SCKO animals was simply the result of SC death,
we assessed changes in SCnumbers in the nerves of these animals.
Remarkably, we found no differences in the number of SC nuclei
betweenTfam-SCKO sciatic nerve and littermate controls up to 8
months of age (Fig. 7a,b). Moreover, by crossing Tfam-SCKO
mice to Cre-inducible Rosa26-YFP reporter animals, we were
able to confirm that, at all ages examined, Tfam-deficient SCs
present in Tfam-SCKO nerves (identified by their excision-
dependent YFP fluorescence) remained viable (Fig. 7a,c). These
results indicate that the survival of Tfam-deficient SCs was not
compromised despite severe mtDNA depletion and respiratory
chain abnormalities.
Consistent with the viability of Tfam-SCKO SCs, we did not
detect any differences in TUNEL staining, a marker of cell death,
between Tfam-SCKO sciatic nerve and controls at different ages
(Fig. 7a,d). Similarly, staining with an antibody that recognizes
the proliferationmarker phosphohistone 3 showed no changes in
proliferation that could compensate for the potential loss of
Tfam-deficient SCs in Tfam-SCKOnerves (data not shown). The
pathology observed in Tfam-SCKOs, therefore, was not due to
the loss of SCs. Together, our findings indicate that normal mi-
tochondrial function is not required for SC survival, but is essen-
tial for maintenance of axonal survival and normal peripheral
nerve function.
Tfam-deficient SCs support axonal regeneration but fail to
remyelinate following injury
Schwann cells play a critical role in promoting axonal regenera-
tion following peripheral nerve injury. Upon degeneration of pe-
ripheral axons, SCs in the distal stump undergo an orchestrated
process that helps support axonal regeneration (Geuna et al.,
2009). To determine whether disrupting mitochondrial function
affects the ability of SCs to support axonal regeneration, we stud-
ied the response of these cells after peripheral nerve crush injury
in 2-month-old ctrl and Tfam-SCKO mice. At this age, the pe-
ripheral nerves of Tfam-SCKOs show modest pathology that is
mainly limited to unmyelinated fibers yet mitochondrial func-
tion has already been severely disrupted (see above).
We first looked at the initial response of SCs to axonal degen-
eration by assessing changes in SC proliferation and in their abil-
ity to break down existing myelin. Within the first few days after
losing contact with axons, SCs dedifferentiate and start to prolif-
erate (Geuna et al., 2009). Immunostaining of nerves harvested
4 d after injury distal to the site of crush using a phosphohistone
3 antibody showed no impairment in the ability of Tfam-
deficient SCs to proliferate following axonal loss (Fig. 8a,b).
Nerve regeneration also depends on the ability of SCs to break
down existing myelin and remove the resulting debris. This pro-
cess starts immediately after injury and takes place over a period
of 3–6 weeks (Geuna et al., 2009).We did not observe differences
in the amount of myelin debris present in ctrl and Tfam-SCKO
nerves 3 weeks after injury, suggesting that disruption of mito-
chondrial function in SCs does not interfere with their ability to
Figure 6. Tfam-SCKOs have behavioral deficits consistent with early loss of unmyelinated
fibers followedby extensive degeneration ofmyelinated axons.a, Two-month-old Tfam-SCKOs
are less sensitive to an applied noxious heat stimulus than ctrl littermates (p 0.01, two-tailed
Student’s t test), as shown by an increased withdrawal latency, which indicates loss of unmy-
elinatedC-fibernociceptors. This deficiencypersists in4-month-old Tfam-SCKOmice (p0.01,
two-tailed Student’s t test). b–d, At 2months of age, consistent with the early preservation of
large myelinated motor axons, Tfam-SCKOs do not display significant motor deficits as shown
by the inverted screen test (b) or accelerating rotarod (c). Four-month-old Tfam-SCKOs, how-
ever, spend significantly less time on an inverted screen (p 0.01, two-tailed Student’s t test)
(b) and accelerating rotarod (p 0.01, two-tailed Student’s t test) (d), motor deficits that
indicate the loss of largemyelinated fibers by this age. Error bars indicate SEM. N 4mice per
genotype at each age.
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break down and remove myelin following axonal degeneration
(Fig. 8c).
We next studied the ability of Tfam-deficient SCs to support
axonal regeneration by analyzing toluidine blue-stained plastic
sections of Tfam-SCKO and ctrl nerves collected distal to the site
of crush 3 weeks after injury. At this time, we found that substan-
tial axonal regeneration and SC remyelination had already taken
place in ctrl nerves (Fig. 8d). In Tfam-SCKO nerves, however, we
observed a striking decrease in the number of myelinated fibers
(Fig. 8d). Interestingly, examination of Tfam-SKOnerves by elec-
tronmicroscopy revealed that this decrease inmyelinated profiles
was not due to the inability of Tfam-deficient SCs to support
axonal regrowth. In fact, the total number of fibers (myelinated
and unmyelinated) distal to the crush site was equivalent between
ctrl and Tfam-SCKO nerves 3 weeks after injury (Fig. 8e,f).
Moreover, the majority of regenerated axons in Tfam-SCKO
nerves 3 weeks after injury were associated with SCs in the typical
1:1 ratio (Fig. 8g1–g4). Tfam-deficient SCs, however, failed to
formmature myelin. Given that the proportion of axons of large
enough caliber to induce myelination (
1 m in diameter) was
not different between ctrl and Tfam-SCKOs (Fig. 8h), the inabil-
ity of Tfam-deficient SCs to myelinate is
likely a direct consequence of their dis-
rupted mitochondrial metabolism.
Regenerated Remak bundles were also
absent in Tfam-SCKO nerves compared
with ctrl littermates 3 weeks after crush
injury. Instead, we observed pathological
bundles of unorganized unmyelinated
axons interspersed by bands of Bungner
(Fig. 8g5,g6), similar to those present in
2-month-old Tfam-SCKO mice before
injury. We conclude that disrupting SC
mitochondrial function does not affect
the ability of these glia to dedifferentiate,
proliferate, or support axonal regenera-
tion following injury. Normal SC mito-
chondrial metabolism, however, is
essential for SCs to form mature myelin
and Remak bundles, suggesting that the
formation and maintenance of these ma-
ture structures poses a high metabolic
challenge.
Discussion
In the present study, we describe the gen-
eration and characterization of mice with
disrupted mitochondrial function only in
SCs. We found that the induction of SC-
specific mitochondrial dysfunction did
not affect the survival of these cells but
resulted in a severe, progressive peripheral
neuropathy characterized by extensive ax-
onal degeneration. SCmitochondrial dys-
function, therefore, disrupts the axoglial
interactions required for the long-term
support of axons and is a likely contribu-
tor to the clinical impairment of patients
suffering from peripheral neuropathies.
Mitochondrial dysfunction is a com-
mon cause of peripheral neuropathies. An
extensive body of literature has now ad-
dressed how neuronal/axonal mitochon-
dria may contribute to the pathology
observed in these diseases (Niemann et al., 2006; Baloh, 2008).
The results described above show for the first time that disrupted
mitochondrial function specifically in SCs can itself also cause
axonal degeneration and peripheral nerve disease. These findings
are consistent with observations in patients suffering from poly-
neuropathies associated with diabetes, HIV/AIDS, and mito-
chondrial disorders, in which most nerve mitochondrial
abnormalities are localized to SCs (Schroder, 1993; Kalichman
et al., 1998).
Moreover, the Tfam-SCKOmice generated in our study reca-
pitulated a number of critical pathological features of human
peripheral neuropathies. Disrupting mitochondrial metabolism
specifically in SCs was sufficient to induce both axonal degener-
ation as well as demyelination. Tfam-SCKOs also displayed distal
weakness and sensory deficits, two common problems in human
patients. Finally, Tfam-SCKOs suffered preferential early loss of
unmyelinated C-fibers followed by the degeneration of large-
caliber myelinated axons. This was of particular interest because
preferential loss of small-caliber unmyelinated fibers is charac-
teristic of peripheral and optic neuropathies associated with
Figure7. SCmitochondrial dysfunction does not compromise SC survival.a,b, Nuclear staining (a, DAPI) andquantification (b)
shows that there is no difference in the number of SC nuclei between Tfam-SCKO and ctrl sciatic nerves at different ages. a, c,
Quantification of Rosa-YFP immunofluorescence (a, YFP/DAPI; c) in Tfam-SCKO/Rosa-YFP nerves at different ages shows that the
majority of SCs are Tfam-deficient at all ages. a, d, Quantification of TUNEL immunohistochemistry (a, TUNEL/DAPI; d) of Tfam-
SCKO and ctrl littermate shows no differences in the number of TUNEL-positive cells at different ages, indicating that SCs are able
to survive despite the disruption in their mitochondria. Scale bar, 100m. Error bars indicate SEM. n 3 mice per genotype at
each age.
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systemic diseases such as diabetes or with
exposure to environmental toxins (Ken-
nedy et al., 1996; Sadun, 2002; McArthur
et al., 2005). Together, our results indicate
that SC mitochondria are underappreci-
ated contributors to the abnormalities ob-
served in peripheral neuropathies.
Furthermore, key pathological features
commonly encountered in human pe-
ripheral nerve disease can potentially be
explained by SC-specific mitochondrial
dysfunction.
The findings described in the present
paper are consistent with a growing body
of literature that implicates glial dysfunc-
tion in a number of neurodegenerative
diseases traditionally thought to be cell
autonomous. This is best exemplified by
amyotrophic lateral sclerosis (ALS), a dis-
ease characterized by premature death of
motor neurons that is sometimes linked
to dominant mutations in the antioxidant
protein superoxide dismutase 1 (SOD1)
(Rosen et al., 1993). While neuronal ex-
pression of mutant SOD1 in transgenic
mousemodels of ALSwas found to be im-
portant for the initial timing of disease
onset (Boillee et al., 2006; Yamanaka et al.,
2008; Wang et al., 2009), expression in
microglia cells (Boillee et al., 2006; Wang
et al., 2009) and astrocytes (Yamanaka et
Figure8. Tfam-deficient SCs support axonal regenerationbut fail to remyelinate following injury.a,b, Phosphohistone3 (PH3)
immunostaining (a) and quantification (b) show that there is no difference in the number of proliferating SCs (arrowheads)
4
between Tfam-SCKO and ctrl sciatic nerves 4 d after crush in-
jury. Scale bar, 100m. Error bars indicate SEM.n at least 3
mice per genotype. c, Quantification of the amount of myelin
debris present in ctrl and Tfam-SCKO nerves 3 weeks after
crush injury shows no impairment in the ability of Tfam-
deficient SCs tobreakdownexistingmyelin. Error bars indicate
SEM. n 3 mice per genotype. d, Quantification of the num-
ber of myelinated profiles in ctrl and Tfam-SCKO nerves 3
weeks after crush distal to the site of injury shows a significant
decrease (p 0.001, two-tailed Student’s t test) in the num-
ber of myelinated profiles formed by Tfam-deficient SCs fol-
lowing injury. Error bars indicate SEM. n  3 mice per
genotype. e, Electron micrographs of ctrl and Tfam-SCKO
nerves 3 weeks after crush depicting the inability of Tfam-
deficient SCs to formmature myelin even though they are ca-
pable of supporting axonal regeneration. Scale bar, 2m. f,
Quantification of the total number of fibers (myelinated and
unmyelinated) distal to the site of injury 3 weeks after crush
shows no differences between Tfam-SCKO and ctrl nerves,
confirming that Tfam-deficient SCs are able to support axonal
regeneration. Error bars indicate SEM. n 3 mice per geno-
type.g, Electronmicrographs of ctrl (g1) and Tfam-SCKO (g2–
g4) large-caliber fibers distal to the site of injury 3weeks after
crush showing that, while Tfam-deficient SCs are capable of
ensheathing axons and forming one-to-one associations with
them (arrowheads, axons; arrows, SCs), they are not able to
formmaturemyelin. RegeneratingRemakbundles arepresent
in ctrl nerves (g5) but are absent in Tfam-SCKO nerves (g6;
arrowheads, axons; arrows, SCs). h, Proportion of axons
1
m is similar between Tfam-SCKO and ctrl nerves following
injury and cannot explain the absence ofmyelin in Tfam-SCKO
nerves.
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al., 2008) was found to significantly contribute to disease pro-
gression. Similarly, in a mouse model of Parkinson’s disease,
oligodendrocyte-specific overexpression of the disease-related
protein -synuclein resulted in neurodegeneration (Yazawa et
al., 2005). A central role for glia in diseases such as Huntington’s,
spinocerebellar ataxia, or Alzheimer’s has also been reported (for
review, see Ilieva et al., 2009). The development of effective ther-
apies for peripheral neuropathies and neurodegenerative disor-
ders, therefore, will need to address the contribution of SCs and
other glia to disease progression.
An unexpected finding of our work was that severe mtDNA
depletion and respiratory chain abnormalities in the SCs of
Tfam-SCKO mice did not affect their survival. This observation
suggests that SCs have an adaptable energy metabolism and that
their survival and ATP production are not fully dependent on
mitochondrial function. Previous studies looking at the effect of
Tfam deletion in a number of tissues have indeed reported cell-
specific metabolic changes that take place following the Tfam
deletion-induced disruption of the electron transport chain. For
example, following the muscle-specific deletion of Tfam, myo-
cytes increased their mitochondrial mass to compensate for any
deficiencies in their respiratory chain (Wredenberg et al., 2002).
Cardiomyocytes, however, were reported to switch to a primarily
glycolyticmetabolism in response to the heart-specific excision of
Tfam (Hansson et al., 2004). Some of these adaptations likely
account for the limited or largely delayed cell death observed in
several tissue-specific TfamKOs (Larsson et al., 1998;Wang et al.,
1999; Silva et al., 2000; Sorensen et al., 2001; Wredenberg et al.,
2002). Specific metabolic adaptations following Tfam depletion-
induced mitochondrial dysfunction may also explain why SC vi-
ability was not affected in Tfam-SCKO mice.
SCs have, in fact, been hypothesized to be largely glycolytic
and rely on the nonoxidative catabolism of glucose to meet their
energy needs (Pellerin and Magistretti, 2003). This idea is sup-
ported by the observation that, in explant systems, SCs take up a
disproportionately large amount of glucose (Vega et al., 2003).
The fact that disruption of mitochondrial energy metabolism in
Tfam-SCKO mice did not affect SC survival provides indirect
support for this hypothesis. Our current knowledge of the basic
energymetabolism and requirements of SCs, however, is still very
rudimentary. Future work aimed at understanding themetabolic
changes that take place in SCs following Tfam deletion-induced
respiratory chain deficiency should provide valuable insight into
both the biology and pathology of SCs.
Following peripheral nerve injury, SCs undergo a process of
dedifferentiation, proliferation, and formation of tubular struc-
tures known as bands of Bungner, which, together with their
production of neurotrophic factors, help support axonal regen-
eration (Geuna et al., 2009). Interestingly, we found that Tfam
depletion-induced mitochondrial dysfunction did not interfere
with the ability of SCs to perform these duties and support axonal
regrowth. However, Tfam-deficient SCs failed to redifferentiate
and formmature Remak bundles andmyelin sheaths after having
promoted axonal regeneration. The high metabolic challenge
posed by the reconstruction of thesemature structures, therefore,
appears to require an undisturbed SC mitochondrial anaplerotic
metabolism. Elucidation of deficiencies in the intermediate me-
tabolism of Tfam-SCKOs could thus provide new targets whose
manipulationmaypromote the remyelinationand the restorationof
normal nerve function in patients suffering from mitochondrial-
related peripheral neuropathies.
SCs have a primary role in supporting axonal function and
survival (Chen et al., 2003; Reddy et al., 2003; Meyer zu Horste et
al., 2007), yet themechanisms and cellularmachinery underlying
SC preservation of axons still remain largely unknown. Others
have hypothesized that glial support requires axonal ensheath-
ment as well as somemyelin-related proteins. Trophic support of
axons through neurotrophic factors has also been postulated as a
potential mechanism behind glia-mediated axonal maintenance.
Metabolic support of axons by ensheathing cells is also a likely but
poorly understoodmechanism of axonal preservation (Nave and
Trapp, 2008). For example, SCs may support axons through the
transfer ofmetabolites or by helping axons eliminate certain toxic
species, as is the case between CNS neurons and astrocytes (Be-
narroch, 2005). Our results show that SC mitochondria are es-
sential for the SC-mediated support of axonal function and
survival. Given the central role ofmitochondria in cellular energy
and anaplerotic metabolism, we speculate that the axonal degen-
eration in Tfam-SCKOs reflects a disruption of SC-mediated
metabolic support of axons. The preferential loss of small unmy-
elinated fibers early in the Tfam-SCKO disease process would
then reflect a greater dependence of these fibers on SCmetabolic
support. Consistent with this hypothesis, unmyelinated axons
have been found to be more energetically demanding than my-
elinated axons and are estimated to consume 2.5- to 10-foldmore
energy per action potential generated (Wang et al., 2008).
In summary, Tfam-SCKOs are, to our knowledge, the first
SC-specific metabolic mutant that recapitulates some of the pa-
thology of human peripheral neuropathies. These mice demon-
strate that SC-specific mitochondrial dysfunction can be
sufficient to cause both demyelination and axonal degeneration.
Our study also provides evidence that SC mitochondria help
maintain the axoglial interactions required for the long-term
support of axons. A greater understanding of SC mitochondria
and how to prevent their dysfunction is, therefore, relevant to the






Figure 1 shows that Tfam-SCKOs initially develop andmyelinate normally.
This material has not been peer reviewed.
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